Basanite (BASA) 10-K/A 10 May 24 2023 FY Annual report (amended) Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2023	Apr. 12, 2024	Jun. 30, 2023
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	Amendment No 1
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-53574
Entity Registrant Name	Basanite, Inc.
Entity Central Index Key	0001448705
Entity Tax Identification Number	20-4959207
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2041 NW 15th Avenue
Entity Address, City or Town	Pompano Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33069
City Area Code	(954)
Local Phone Number	532-4653
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 3,085,882
Entity Common Stock, Shares Outstanding		260,156,796
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	6849
Auditor Name	Hudgens CPA, PLLC
Auditor Location	Houston, Texas

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 55,248	$ 30,340
Accounts receivable, net	40,222	67,960
Inventory
Prepaid expenses		137,370
Deposits and other current assets
TOTAL CURRENT ASSETS	95,470	235,670
Lease right-of-use asset	56,915	153,270
Fixed assets, net	402,271	530,238
TOTAL NON CURRENT ASSETS	459,186	683,508
TOTAL ASSETS	554,656	919,178
CURRENT LIABILITIES
Accounts payable	1,762,390	1,713,045
Accrued expenses	1,207,545	438,870
Accrued legal liability		165,000
Notes payable	270,000	304,243
Notes payable - related party	1,750,000	605,000
Notes payable - convertible - related party, net	2,144,357	2,144,357
Due to shareholders	475,000	505,000
Subscription liability		1,300,000
Lease liability - current portion	56,915	93,186
TOTAL CURRENT LIABILITIES	7,666,207	7,268,701
Lease liability - net of current portion		56,915
TOTAL LIABILITIES	7,666,207	7,325,616
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 259,156,796 and 253,217,402 shares issued and outstanding, respectively	259,157	253,218
Additional paid-in capital	48,891,681	47,433,354
Accumulated deficit	(56,262,389)	(54,093,010)
TOTAL STOCKHOLDERS' EQUITY(DEFICIT)	(7,111,551)	(6,406,438)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 554,656	$ 919,178

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	259,156,796	253,217,402
Common stock, shares outstanding	259,156,796	253,217,402

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue
Products sales – rebar	$ 376,096	$ 1,356,165
Total cost of goods sold	248,313	2,025,926
Gross (loss) profit	127,783	(669,761)
OPERATING EXPENSES
Selling, general, and administrative expenses	1,730,733	3,585,955
Total operating expenses	1,730,733	3,585,955
NET LOSS FROM OPERATIONS	(1,602,950)	(4,255,716)
OTHER INCOME (EXPENSE)
Gain on settlement of legal contingency
Liquidated Damages		(426,759)
Gain on settlement of lease liabilities		52,712
Miscellaneous income		30
Loss on extinguishment of debt
Loan forgiveness		170,096
Interest expense	(566,429)	(512,162)
Total other income (expense)	(566,429)	(716,083)
NET LOSS	$ (2,169,379)	$ (4,971,799)
Net loss per share – basic	$ (0.01)	$ (0.03)
Net loss per share – diluted	$ (0.01)	$ (0.03)
Weighted average number of shares outstanding – basic	256,834,618	251,488,656
Weighted average number of shares outstanding – diluted	256,834,618	251,488,656

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021		$ 248,842	$ 46,054,126	$ (46,121,210)	$ 181,758
Beginning balance, shares at Dec. 31, 2021		248,840,144
Warrants and options exercised for cash		$ 1,833	223,167		225,000
Warrants and options exercised for cash, shares		1,833,333
Stock-based compensation		$ 422	297,320		297,742
Stock-based compensation, shares		422,713
Stock issued from subscription liability		$ 2,121	647,470		649,591
Stock issued for cash, shares		2,121,212
Warrants issued to management			211,271		211,271
Net loss				(7,971,799)	(7,971,799)
Ending balance, value at Dec. 31, 2022		$ 253,218	47,433,354	(54,093,010)	(6,406,438)
Ending balance, shares at Dec. 31, 2022		253,217,402
Stock-based compensation		$ 2,000	162,266		164,266
Stock-based compensation, shares		2,000,000
Stock issued from subscription liability		$ 3,939	1,296,061		1,300,000
Stock issued for cash, shares		3,939,394
Net loss				(2,169,379)	(2,169,379)
Ending balance, value at Dec. 31, 2023		$ 259,157	$ 48,891,681	$ (56,262,389)	$ (7,111,551)
Ending balance, shares at Dec. 31, 2023		259,156,796

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,169,379)	$ (7,971,799)
Adjustments to reconcile net loss to net cash used in operating activities:
Lease right-of-use asset amortization	96,355	333,203
Depreciation	127,967	100,670
Loss on impairment of equipment and deposits		2,599,585
Gain on settlement of lease liability		(52,712)
Bad debt expense		454,534
Loan forgiveness		(170,096)
Stock-based compensation	164,266	509,013
Changes in operating assets and liabilities:
Prepaid expenses	137,370	(9,564)
Inventory		714,655
Accounts receivable	27,738	(514,677)
Deposits and other current assets
Accounts payable and accrued expenses	653,020	1,030,968
Due to shareholders		505,000
Lease liability	(93,186)	(359,429)
Net cash used in operating activities	(1,055,849)	(2,830,650)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment		(178,115)
Proceeds from sale of equipment		450,000
Net cash used in investing activities		271,885
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock, net of costs		649,591
Proceeds from exercise of warrants and options		225,000
Proceeds from subscription liability		1,300,000
Repayment of convertible notes payable and convertible notes payable related party
Proceeds from notes payable and notes payable related parties	1,145,000	305,000
Repayment of notes payable and notes payable related parties	(64,243)
Net cash provided by financing activities	1,080,757	2,479,591
NET (DECREASE) INCREASE IN CASH	24,908	(79,174)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	30,340	109,514
CASH AND CASH EQUIVALENTS AT END OF PERIOD	55,248	30,340
Supplemental cash flow information:
Cash paid for interest		45,031
Supplemental disclosure of non-cash investing and financing activities:
Shares issued from subscription liability	1,300,000
Conversion of accrued interest to convertible notes		$ 454,612

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure [Table]
Net Income (Loss) Attributable to Parent	$ (2,169,379)	$ (7,971,799)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

ORGANIZATION, NATURE OF BUSINES

ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN	12 Months Ended
	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN	NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (A) Description of Business On May 30, 2006, Basanite, Inc. was organized as a Nevada corporation. Basanite and its wholly owned subsidiaries are herein referred to as “Basanite,” the "Company", “we”, “our”, or “us”. Currently based in Pompano Beach, Florida, the Company intends to manufacture concrete-reinforcing products made from basalt fiber reinforced polymers (“BFRP”), such as its primary product BasaFlex. This UV-stable, chemical, acid and moisture resistant material is sustainable and environmentally friendly and has been engineered to replace steel as it never rusts, therefore, addressing the industry’s current corrosion issues. The Company’s wholly owned subsidiary created in 2018, Basanite Industries, LLC (“BI”) manufactures BasaFlex™, a basalt fiber reinforced polymer rebar. BFRP rebar is a stronger, lighter, sustainable, non-conductive and non-corrosive alternative for traditional steel rebar and wire mesh. BI previously leased a fully permitted and Underwriters Laboratories (“UL”) approved 36,900 square foot facility located in Pompano Beach, Florida. BI’s operations team is currently in the processes of searching for, optimizing, and scaling the manufacturing plant to produce 11,000 to 17,000 linear feet of BFRP rebar per line, per day, depending on the product mix. BI’s own fully equipped test lab will be utilized to evaluate, validate, and verify each product’s performance attributes. The company does not hold inventory at this time for sale, has no current facilities for operations but is actively seeking funding through debt equity to restart operations and searching for a new location in which to operate full manufacturing activities. • BasaFlex™ never rusts – steel reinforcement products rust, causing time and repair costs down the road; • BasaFlex™ is sustainable; with a longer lifecycle – production of our products results in exceptionally low carbon footprint when compared with steel. The lack of corrosion allows the “lifespan” of concrete products to be significantly longer; and • BasaFlex™ has a lower final, in place cost – the physical nature of our products relative to steel (4X lighter, easily transportable, “coil-able”, safer and easier to use) reduces the all-in cost of reinforcement when all factors are considered. (B) Liquidity and Management Plan – Going Concern Since inception, the Company has incurred net operating losses and used cash in operations. As of December 31, 2023 and 2022, respectively, the Company reported: • an accumulated deficit of approximately $ 56.3 54.0 • a working capital deficiency of approximately $ 7.6 7 • cash used in operations of approximately $ 1.1 2.8 Losses have principally occurred as a result of the substantial resources required for product research and development and for the marketing of the Company's products; including the general and administrative expenses associated with the organization. At December 31, 2023, the Company had cash of $ 55,248 30,340 We have historically satisfied our working capital requirements through the sale of restricted common stock and the issuance of warrants and promissory notes. Until we are able to internally generate positive cash flow, we will attempt to fund working capital requirements through third party financing, including through private placement of our securities as well as bridge loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. These conditions raise substantial doubt about the Company's ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides the opportunity for the Company to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (A) Use of Estimates in Financial Statements The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of our common stock, risk-free interest rates and the expected dividend yield of our common stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. (B) Principles of Consolidation The consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC, formerly known as Rockstar Acquisitions, LLC. All intercompany balances have been eliminated in consolidation. (C) Cash The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company ("FDIC") up to $ 250,000 (D) Inventories The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Raw materials inventory consists primarily of basalt fiber and other necessary elements to produce basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. The company has maintained $ 0 The Company’s inventory at December 31, 2023 and 2022 was comprised of: Schedule of Inventories December 31, 2023 2022 Finished goods $ — $ — Work in process — — Raw materials and supplies — — Total inventory $ — — (E) Fixed assets Fixed assets are stated at cost, subject to adjustments for impairment, less accumulated depreciation and amortization. Depreciation and amortization are computed using a straight-line method over the following estimated useful lives: Schedule of depreciation and amortization periods for fixed assets Computer equipment 3 Machinery 7 Leasehold improvements 15 Office furniture and equipment 5 Land improvements 15 Website development 3 Maintenance and repairs are charged to expenses as incurred, and improvements to leased facilities and equipment are capitalized. Fixed assets consist of the following: Schedule of fixed assets December 31, December 31, 2023 2022 Computer equipment $ 203,193 $ 203,193 Machinery 728,245 728,245 Total fixed assets 931,438 931,438 Accumulated depreciation (529,167 ) (401,201 ) Total fixed assets, net $ 402,271 $ 530,237 Depreciation expense for the year ended December 31, 2023 was $ 127,967 100,670 The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by that asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. During the year ended December 31, 2022, the Company determined that the construction in process related to the custom machines should be fully impaired due to the uncertainty as to if or when the machines would be received. The Company recognized an impairment of these assets in the amount of $ 2,599,585 (F) Deposits and other current assets None. (G) Accrued expenses The Company’s accrued expenses consist of the following: Schedule of accrued expenses December 31, December 31, 2023 2022 Accrued payroll and taxes $ 202,187 $ 22,847 Accrued interest 998,826 340,521 Other accrued expenses 64,096 775,502 Total accrued expenses $ 1,265,109 $ 1,138,870 (H) Accrued legal liabilities The Company’s accrued legal liabilities consist of the following: Schedule of accrued legal liabilities consist December 31 December 31 2023 2022 Accrued legal fees $ — $ 165,000 Total accrued legal liability $ — $ 165,000 (I) Loss Per Share The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company’s net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. The following are potentially dilutive shares not included in the loss per share computation: Schedule of dilutive shares not included in the loss per share computation December 31, December 31, 2023 202 Options 1,477,778 1,477,778 Warrants 125,295,757 139,555,757 Convertible shares 8,016,068 8,016,068 134,789,603 148,003,598 (J) Stock-Based Compensation The Company recognizes compensation costs to employees under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company issued 2,000,000 0 0 20,000 The Company issues various equities as compensation to consultants, employees, directors, and investors. The Company issued 8,316,652 11,303,030 0 1,783,284 As of December 31, 2023 and 2022, $ 0 For the years ended December 31, 2023 and 2022, total equity-based compensation expense amounted to $ 0 509,013 The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the years ended December 31, 2023 and 2022: Schedule of fair value assumptions 2023 2022 Expected price volatility 162.12 167.20% 144.79 148.70% Risk-free interest rate 0.78 1.26 0.78 1.26 Expected life in years 5 5 Dividend yield — — (K) Income Taxes The Company has not recorded any income tax expense or benefit for the years ended December 31, 2023 and 2022 due to its history of net operating losses. The provision for income taxes was calculated as a result of the following (in thousands). The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities are as follows (in thousands): Schedule of deferred tax assets and liabilities December 31, 2023 2022 Deferred tax assets: Net operating loss carryforwards $ 2,169 $ 7,587 Accruals and allowances 1,265 454 ROU liability amortization — 359 Stock-based compensation — 1,344 Total deferred tax assets 3,434 9,744 Valuation allowance (3,434 ) (9,744 ) Total deferred tax assets net of valuation allowance — — Deferred tax liabilities: ROU asset amortization — (333 ) Depreciation (127 ) (101 ) Total deferred tax liabilities (127 ) (434 ) Valuation allowance 127 434 Total deferred tax liabilities net of valuation allowance — — Net deferred tax assets $ — $ — As of December 31, 2023, the Company has a valuation allowance of approximately $ 3.4 56.2 As of December 31, 2022, the Company has a valuation allowance of approximately $ 9.7 54.0 The amount of the valuation allowance represented a decrease of approximately $ 5.5 28.4 27.2 Management has evaluated all other tax positions that could have a significant effect on the financial statements and determined the Company had no The Company files income tax returns in the U.S. federal jurisdiction and Florida. The Company is subject to U.S. federal and Florida state tax examinations for certain years after 2018.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Dec. 31, 2023
Recent Accounting Pronouncements
RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS There are several new accounting pronouncements issued or proposed by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial position or operating results. In June 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments – Credit Losses (Topic 326). The ASU introduces a new credit loss methodology, Current Expected Credit Losses (CECL), which requires earlier recognition of credit losses, while also providing additional transparency about credit risk. Since its original issuance in 2016, the FASB has issued several updates to the original ASU. The CECL Methodology utilizes a lifetime “expected credit loss” measurement objective for the recognition of credit losses for loans, held-to-maturity securities and other receivables at the time the financial asset is originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. The methodology replaces the multiple existing impairment methods in current GAAP, which generally require that a loss be incurred before it is recognized. For available-for-sale securities where fair value is less than cost, credit related impairment, if any, will be recognized through an allowance for credit losses and adjusted each period for changes in credit risk. The CECL methodology represents a significant change from existing US GAAP and may result in material changes to the Company’s accounting for financial assets. The Company is evaluating the effect that ASU 2016-13 will have on its Consolidated Financial Statements and related disclosures. In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and other Options (Subtopic 70-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s instruments by removing major separation models required under current accounting principles generally accepted in the United States of America (“U.S. GAAP”). ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exceptions and also simplifies the diluted earnings per share calculation in certain areas. The standard is effective for public business entities, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years and interim periods within those fiscal years beginning after December 15, 2021. For all other entities, the standard will be effective for fiscal years beginning after December 12, 2023. Early adoption is permitted but no earlier than fiscal years beginning after December 15, 2020, and adoption must be as of the beginning of the Company’s annual fiscal year. The standard was adopted on January 1, 2021. By no longer recording embedded conversion features separately from the convertible debt instrument, and instead as a single liability, the Company’s financial statements will reflect a more simplified view of convertible debt instruments and cash interest expense that is more relevant than an imputed interest expense that results from the separation of conversion features previously required by U.S. GAAP.

OPERATING LEASE

OPERATING LEASE	12 Months Ended
	Dec. 31, 2023
Operating Lease
OPERATING LEASE	NOTE 4 – OPERATING LEASE On January 18, 2019, the Company entered into an agreement to lease approximately 25,470 square feet of office and manufacturing space in Pompano Beach, Florida through March 2024. On March 25, 2019, the Company entered into an amendment to the agreement to increase the square footage of leased premises to 36,900 square feet, increasing the Company’s base rent obligation to be approximately $ 33,825 In accordance with ASC 842, on January 18, 2019, the Company entered into and recorded a lease right-of-use asset and a lease liability at a present value of $ 1,405,804 As of December 31, 2022 the Company vacated the lease and no further obligation is due. The Company’s headquarters were moved to 2660 NW 15 CT, Unit 108, Pompano Beach, FL 33069. As of this filing the Company has not entered into a lease agreement with the landlord. Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used the incremental borrowing rate based on the information available at the lease commencement date. As of December 31, 2022, the weighted-average remaining lease term is 5.15 15.0% 0 424,593

NOTES PAYABLE _ CONVERTIBLE

NOTES PAYABLE – CONVERTIBLE	12 Months Ended
	Dec. 31, 2023
Notes Payable Convertible
NOTES PAYABLE – CONVERTIBLE	NOTE 5 – NOTES PAYABLE – CONVERTIBLE Notes payable – convertible totaled $ 0 0 On August 3, 2020, the Company issued an unsecured convertible promissory note to an accredited investor in exchange for $ 10,000 18% 18% February 3, 2021 0.001 500,000 0.01 10,000 1,007 Interest expense for the Company’s convertible notes payable was $ 0 10 0 0

NOTES PAYABLE _ CONVERTIBLE _ R

NOTES PAYABLE – CONVERTIBLE – RELATED PARTY	12 Months Ended
	Dec. 31, 2023
Notes Payable Convertible Related Party
NOTES PAYABLE – CONVERTIBLE – RELATED PARTY	NOTE 6 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY Notes payable – convertible – related party totaled $ 2,144,357 2,144,357 On August 3, 2020, the Company issued an unsecured convertible promissory note to Michael V. Barbera, the Chairman of the Board, in exchange for $ 25,000 18% 0.001 500,000 0.01 25,000 2,518 On August 3, 2020, the Company issued a secured convertible promissory note to certain investors in exchange for $ 1,000,000 750,000 On February 12, 2021, the Company exchanged the original debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $ 1,610,005 20% 3 1,000,000 110,005 15,000,000 5 3,686,123 On May 12, 2021, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $ 1,689,746 20% 1,610,005 79,742 7,500,000 5 0.35 1,874,705 On September 15, 2022, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $ 2,144,357 20% 1,689,746 454,612 Interest expense for the Company’s convertible notes payable – related parties was $ 0 107,218 Accrued interest for the Company’s convertible notes payable – related parties at December 31, 2023 and December 31, 2022 was $ 554,595 107,218

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
NOTES PAYABLE	NOTE 7 – NOTES PAYABLE Notes payable totaled $ 270,000 605,000 During the year ended December 31, 2018, the Company issued unsecured, 4% 260,425 191,965 15,729 150,000 57,694 1,136,364 five 0.396 On March 31, 2022 and March 30, 2021, the Company entered financing arrangements to finance the insurance premiums for its liability coverage. The financings have an interest rate of 9.40% and last through March of 2023. The balance as of December 31, 2022 and 2021 was $ 5,200 6,015 On February 25, 2021, the Company entered a promissory note agreement with its bank for $ 165,747 1.0% 0 165,747 On April 2, 2021, the Company issued a promissory note with an investor in exchange for $ 200,000 18% 2,000,000 0.20 5 On April 9, 2021, the Company issued a promissory note with an investor in exchange for $ 50,000 18% 500,000 5 On April 16, 2021, the Company issued a promissory note with an investor in exchange for $ 25,000 18% 250,000 0.25 5 On April 16, 2021, the Company issued a promissory note with an investor in exchange for $ 20,000 18% 200,000 0.25 5 On April 16, 2021, the Company issued a promissory note with an investor in exchange for $ 300,000 18% 3,000,000 0.25 5 6,000,000 5,199 1,487,386 Interest expense for the Company’s notes payable was $ 5,625 122 Accrued interest for the Company’s notes payable at December 31, 2022 and December 31, 2021 was $ 159,630 63,310

NOTES PAYABLE _ RELATED PARTY

NOTES PAYABLE – RELATED PARTY	12 Months Ended
	Dec. 31, 2023
Notes Payable Related Party
NOTES PAYABLE – RELATED PARTY	NOTE 8 – NOTES PAYABLE – RELATED PARTY Notes payable – related party totaled $ 1,750,000 605,000 On January 16, 2020, the Company entered into a demand note agreement with our Board Chairman, Michael V. Barbera, in the amount of $ 50,000 10% 12% On April 2, 2021, the Company issued a promissory note with Paul Sallarulo, a member of our Board of Directors, in exchange for $ 150,000 18% October 2, 2022 1,500,000 April 1, 2024 On April 2, 2021, the Company issued a promissory note with Michael V. Barbera, our Chairman of the Board, in exchange for $ 150,000 18% October 2, 2022 1,500,000 April 1, 2024 On August 31, 2022 the Company issued a promissory note to a board member in exchange for $ 37,000 10% August 31, 2024 On August 22, 2022 the Company issued a promissory note to a board member in exchange for $ 20,000 10% August 22, 2024 On August 22, 2022 the Company issued a promissory note to a board member in exchange for $ 5,000 10% August 22, 2024 On August 29, 2022 the Company issued a promissory note to a board member in exchange for $ 25,000 10% August 29, 2024 On August 29, 2022 the Company issued a promissory note to a board member in exchange for $ 10,000 10% August 29, 2024 On August 31, 2022 the Company issued a promissory note to a board member in exchange for $ 13,000 10% August 31, 2024 On September 9, 2022 the Company issued a promissory note to a board member in exchange for $ 60,000 10% August 16, 2024 On September 9, 2022 the Company issued a promissory note to a board member in exchange for $ 10,000 10% September 9, 2024 On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $ 10,000 10% September 9, 2024 On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $ 15,000 10% September 9, 2024 On September 9, 2022 the Company issued a promissory note to an investor and advisor to the board, in exchange for $ 15,000 10% September 9, 2024 On September 22, 2022 the Company issued a promissory note to a board member in exchange for $ 42,500 18% September 22, 2024 On February 14, 2023 the Company issued a promissory note to a board member in exchange for $ 10,000 20% February 13, 2024 On February 24, 2023 the Company issued a promissory note to a board member in exchange for $ 50,000 20% February 23, 2024 On March 3, 2023 the Company issued a promissory note to a board member in exchange for $ 15,000 20% March 2, 2024 On March 24, 2023 the Company issued a promissory note to a board member in exchange for $ 15,000 20% March 23, 2024 On April 12, 2023 the Company issued a promissory note to a board member in exchange for $ 150,000 20% April 11, 2024 On April 28, 2023 the Company issued a promissory note to a board member in exchange for $ 100,000 20% April 27, 2024 On May 12, 2023 the Company issued a promissory note to a board member in exchange for $ 100,000 20% May 11, 2024 On June 5, 2023 the Company issued a promissory note to a board member in exchange for $ 100,000 20% June 4, 2024 On July 25, 2023 the Company issued a promissory note to a board member in exchange for $ 200,000 20% July 24, 2024 On September 11, 2023 the Company issued a promissory note to a board member in exchange for $ 150,000 20% September 10, 2024 On September 11, 2023 the Company issued a promissory note to an advisor to the board in exchange for $ 50,000 20% September 10, 2024 On November 2, 2023 the Company issued a promissory note to a board member in exchange for $ 100,000 20% November 1, 2024 On December 12, 2023 the Company issued a promissory note to a board member in exchange for $ 75,000 20% December 11, 2024 On September 22, 2022 the Company issued a promissory note to an investor and advisor to the board in exchange for $ 42,500 18% September 22, 2024 Interest expense for the Company’s notes payable – related party was $ 566,429 121,932 Accrued interest for the Company’s notes payable at December 31, 2023 and December 31, 2022 was $ 287,725 121,932

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 9 – COMMITMENTS AND CONTINGENCIES On July 9, 2021 the Company proposed a liquidation of liability to an individual with regard to a dispute concerning the acquisition of a territory from Rockstar LLC. The proposed settlement would be 500,000 165,000 No commitments and contingencies to be disclosed for year end December 31, 2022. Legal Matters From time to time, we may become involved in legal proceedings that, individually or in the aggregate, could have a material adverse effect on our business, financial condition, cash flows, or results of operations. As of the date of this report, the Company has filed a lawsuit in the state of South Carolina against Upstate Custom Products, LLC. The lawsuit is based on the contract entered into by both parties in August 2021 in relation to the manufacturing of the protrusion machines exclusively manufactured by Upstate Custom Products. LLC. As of this filing the lawsuit and claim for relief is ongoing. On or about October 2023, the Company was served notice of a pending matter of litigation with GS Capital Partners of New York regarding the liquidated damages fees from the 2021 PIPE investment. As of this filing the matter remains unresolved. Due to our cash flow and liquidity challenges, we have received demand letters from several vendors to our company seeking payment of past due amounts to such vendors. As of the date of this report, such demands have not become formal litigations or other proceedings against our company, but they may become litigations against us in the future. Except as set forth above, as of the date of this report, we are not aware of any proceedings pending against our company. Supplier Agreements Concrete Products of the Palm Beaches On December 10, 2021, the Company entered into an Exclusive Supplier Agreement with Concrete Products of the Palm Beaches, Inc. (“CPPB”) of Riviera Beach, Florida. CPPB engaged the Company as its sole and exclusive supplier of BasaFlex, BasaMix, and BasaMesh. On December 10, 2021, the Company issued a warrant to purchase 40,000,000 The Company generated $ 0 37,116 UMC Technologies, LLC On December 12, 2022, the Company entered into an Exclusive Supplier Agreement with UMC Technologies, LLC. (“UMC”). UMC agreed to utilize the Company as its exclusive supplier for all Company products, and the Company has granted CRBC exclusive distribution rights of the Company’s products in Romania, Republic of Turkey, Chile, Bolivia, and Paraguay. Furthermore, UMC has key relationships that could be a source of additional customers for the Company in other territories with no geographic restrictions. The agreement targets multiple large projects in Europe and South America which Basanite has been specified. The Company has not generated revenue under this contract for the year ended December 31, 2023 or 2022, respectively.

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 10 – STOCKHOLDERS’ DEFICIT On August 17, 2021, the Company conducted the closing of a private placement offering to accredited investors of the Company’s units at a price of $ 0.275 0.33 0.33 During the year ended December 31, 2022, the Company issued a total 2,121,212 649,591 During the year ended December 31, 2023, the Company issued a total 0 0 During the year ended December 31, 2023, the Company issued 2,000,000 100,000 164,266 The Company raised $1,300,000 pursuant to a private placement of Common Stock and exercise of warrants in 2022 – this amount is carried on the balance sheet as a current liability as of December 31, 2022 because the shares had not been issued to the investors at that time. During the year ended December 31, 2023, the Company issued the shares and relieved the subscription liability. Subscription Liability as of December 31, 2023 and 2022 was $ 0 1,300,000

OPTIONS AND WARRANTS

OPTIONS AND WARRANTS	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
OPTIONS AND WARRANTS	NOTE 11 – OPTIONS AND WARRANTS Stock Options: The following table provides the activity in options for the respective periods: Schedule of option activity Weighted Total Options Average Aggregate Outstanding Exercise Price Intrinsic Value Balance at January 1, 2022 1,477,778 $ 0.27 $ — Cancelled — — Balance at December 31, 2022 1,477,778 $ 0.27 $ 798 Issued — — Exercised — — Cancelled — — Balance at December 31, 2022 1,477,778 $ 0.27 $ 798 Options exercisable and outstanding at December 31, 2023 are as follows: Schedule of options and warrants exercisable and outstanding Range of Weighted Average Weighted Average Aggregate Number Remaining Exercise Prices Outstanding Contractual Life (Years) Exercise Price Intrinsic Value $ 0.01 0.50 1,477,778 2.39 $ 0.27 $6,798 $ 0.51 1.00 — 0.27 — — 1,477,778 $6,798 Stock Warrants: The following table provides the activity in warrants for the respective periods: Schedule of warrants activity Weighted Average Aggregate Total Warrants Exercise Price Intrinsic Value Balance at December 31, 2022 139,555,757 $ 0.29 $ 150,667 Granted 7,242,428 0.29 Exercised (1,333,333 ) 0.29 Cancelled (3,545,000 ) — Balance at January 1, 2023 135,435,757 $ 0.29 $ 146,219 Granted — — Exercised — — Cancelled (10,140,000 ) — Balance at December 31, 2023 125,295,757 $ 0.30 $ 135,272 Warrants exercisable and outstanding at December 31, 2023 are as follows: Schedule of warrants exercisable and outstanding Range of Weighted Average Weighted Average Aggregate Number Outstanding Remaining Exercise Prices Contractual Life (Years) Exercise Price Intrinsic Value $ 0.01 0.50 125,295,757 2.65 $ 0.30 $135,272 $ 0.51 1.00 125,295,757 — — — 125,295,757 $135,272

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS On April 11, 2024, the Board of Directors, through a vote of Unanimous Written Consent appointed Mr. Ronald LoRicco, Sr, 59, to serve as the Acting Interim Chief Executive Office

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Use of Estimates in Financial Statements	(A) Use of Estimates in Financial Statements The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of our common stock, risk-free interest rates and the expected dividend yield of our common stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
Principles of Consolidation	(B) Principles of Consolidation The consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC, formerly known as Rockstar Acquisitions, LLC. All intercompany balances have been eliminated in consolidation.
Cash	(C) Cash The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company ("FDIC") up to $ 250,000
Inventories	(D) Inventories The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. Raw materials inventory consists primarily of basalt fiber and other necessary elements to produce basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. The company has maintained $ 0 The Company’s inventory at December 31, 2023 and 2022 was comprised of: Schedule of Inventories December 31, 2023 2022 Finished goods $ — $ — Work in process — — Raw materials and supplies — — Total inventory $ — —
Fixed assets	(E) Fixed assets Fixed assets are stated at cost, subject to adjustments for impairment, less accumulated depreciation and amortization. Depreciation and amortization are computed using a straight-line method over the following estimated useful lives: Schedule of depreciation and amortization periods for fixed assets Computer equipment 3 Machinery 7 Leasehold improvements 15 Office furniture and equipment 5 Land improvements 15 Website development 3 Maintenance and repairs are charged to expenses as incurred, and improvements to leased facilities and equipment are capitalized. Fixed assets consist of the following: Schedule of fixed assets December 31, December 31, 2023 2022 Computer equipment $ 203,193 $ 203,193 Machinery 728,245 728,245 Total fixed assets 931,438 931,438 Accumulated depreciation (529,167 ) (401,201 ) Total fixed assets, net $ 402,271 $ 530,237 Depreciation expense for the year ended December 31, 2023 was $ 127,967 100,670 The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by that asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. During the year ended December 31, 2022, the Company determined that the construction in process related to the custom machines should be fully impaired due to the uncertainty as to if or when the machines would be received. The Company recognized an impairment of these assets in the amount of $ 2,599,585
Deposits and other current assets	(F) Deposits and other current assets None.
Accrued expenses	(G) Accrued expenses The Company’s accrued expenses consist of the following: Schedule of accrued expenses December 31, December 31, 2023 2022 Accrued payroll and taxes $ 202,187 $ 22,847 Accrued interest 998,826 340,521 Other accrued expenses 64,096 775,502 Total accrued expenses $ 1,265,109 $ 1,138,870
Accrued legal liabilities	(H) Accrued legal liabilities The Company’s accrued legal liabilities consist of the following: Schedule of accrued legal liabilities consist December 31 December 31 2023 2022 Accrued legal fees $ — $ 165,000 Total accrued legal liability $ — $ 165,000
Loss Per Share	(I) Loss Per Share The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company’s net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. The following are potentially dilutive shares not included in the loss per share computation: Schedule of dilutive shares not included in the loss per share computation December 31, December 31, 2023 202 Options 1,477,778 1,477,778 Warrants 125,295,757 139,555,757 Convertible shares 8,016,068 8,016,068 134,789,603 148,003,598
Stock-Based Compensation	(J) Stock-Based Compensation The Company recognizes compensation costs to employees under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company issued 2,000,000 0 0 20,000 The Company issues various equities as compensation to consultants, employees, directors, and investors. The Company issued 8,316,652 11,303,030 0 1,783,284 As of December 31, 2023 and 2022, $ 0 For the years ended December 31, 2023 and 2022, total equity-based compensation expense amounted to $ 0 509,013 The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the years ended December 31, 2023 and 2022: Schedule of fair value assumptions 2023 2022 Expected price volatility 162.12 167.20% 144.79 148.70% Risk-free interest rate 0.78 1.26 0.78 1.26 Expected life in years 5 5 Dividend yield — —
Income Taxes	(K) Income Taxes The Company has not recorded any income tax expense or benefit for the years ended December 31, 2023 and 2022 due to its history of net operating losses. The provision for income taxes was calculated as a result of the following (in thousands). The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities are as follows (in thousands): Schedule of deferred tax assets and liabilities December 31, 2023 2022 Deferred tax assets: Net operating loss carryforwards $ 2,169 $ 7,587 Accruals and allowances 1,265 454 ROU liability amortization — 359 Stock-based compensation — 1,344 Total deferred tax assets 3,434 9,744 Valuation allowance (3,434 ) (9,744 ) Total deferred tax assets net of valuation allowance — — Deferred tax liabilities: ROU asset amortization — (333 ) Depreciation (127 ) (101 ) Total deferred tax liabilities (127 ) (434 ) Valuation allowance 127 434 Total deferred tax liabilities net of valuation allowance — — Net deferred tax assets $ — $ — As of December 31, 2023, the Company has a valuation allowance of approximately $ 3.4 56.2 As of December 31, 2022, the Company has a valuation allowance of approximately $ 9.7 54.0 The amount of the valuation allowance represented a decrease of approximately $ 5.5 28.4 27.2 Management has evaluated all other tax positions that could have a significant effect on the financial statements and determined the Company had no The Company files income tax returns in the U.S. federal jurisdiction and Florida. The Company is subject to U.S. federal and Florida state tax examinations for certain years after 2018.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Inventories	Schedule of Inventories December 31, 2023 2022 Finished goods $ — $ — Work in process — — Raw materials and supplies — — Total inventory $ — —
Schedule of depreciation and amortization periods for fixed assets	Schedule of depreciation and amortization periods for fixed assets Computer equipment 3 Machinery 7 Leasehold improvements 15 Office furniture and equipment 5 Land improvements 15 Website development 3
Schedule of fixed assets	Schedule of fixed assets December 31, December 31, 2023 2022 Computer equipment $ 203,193 $ 203,193 Machinery 728,245 728,245 Total fixed assets 931,438 931,438 Accumulated depreciation (529,167 ) (401,201 ) Total fixed assets, net $ 402,271 $ 530,237
Schedule of accrued expenses	Schedule of accrued expenses December 31, December 31, 2023 2022 Accrued payroll and taxes $ 202,187 $ 22,847 Accrued interest 998,826 340,521 Other accrued expenses 64,096 775,502 Total accrued expenses $ 1,265,109 $ 1,138,870
Schedule of accrued legal liabilities consist	Schedule of accrued legal liabilities consist December 31 December 31 2023 2022 Accrued legal fees $ — $ 165,000 Total accrued legal liability $ — $ 165,000
Schedule of dilutive shares not included in the loss per share computation	Schedule of dilutive shares not included in the loss per share computation December 31, December 31, 2023 202 Options 1,477,778 1,477,778 Warrants 125,295,757 139,555,757 Convertible shares 8,016,068 8,016,068 134,789,603 148,003,598
Schedule of fair value assumptions	Schedule of fair value assumptions 2023 2022 Expected price volatility 162.12 167.20% 144.79 148.70% Risk-free interest rate 0.78 1.26 0.78 1.26 Expected life in years 5 5 Dividend yield — —
Schedule of deferred tax assets and liabilities	Schedule of deferred tax assets and liabilities December 31, 2023 2022 Deferred tax assets: Net operating loss carryforwards $ 2,169 $ 7,587 Accruals and allowances 1,265 454 ROU liability amortization — 359 Stock-based compensation — 1,344 Total deferred tax assets 3,434 9,744 Valuation allowance (3,434 ) (9,744 ) Total deferred tax assets net of valuation allowance — — Deferred tax liabilities: ROU asset amortization — (333 ) Depreciation (127 ) (101 ) Total deferred tax liabilities (127 ) (434 ) Valuation allowance 127 434 Total deferred tax liabilities net of valuation allowance — — Net deferred tax assets $ — $ —

OPTIONS AND WARRANTS (Tables)

OPTIONS AND WARRANTS (Tables)	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of option activity	Schedule of option activity Weighted Total Options Average Aggregate Outstanding Exercise Price Intrinsic Value Balance at January 1, 2022 1,477,778 $ 0.27 $ — Cancelled — — Balance at December 31, 2022 1,477,778 $ 0.27 $ 798 Issued — — Exercised — — Cancelled — — Balance at December 31, 2022 1,477,778 $ 0.27 $ 798
Schedule of options and warrants exercisable and outstanding	Schedule of options and warrants exercisable and outstanding Range of Weighted Average Weighted Average Aggregate Number Remaining Exercise Prices Outstanding Contractual Life (Years) Exercise Price Intrinsic Value $ 0.01 0.50 1,477,778 2.39 $ 0.27 $6,798 $ 0.51 1.00 — 0.27 — — 1,477,778 $6,798
Schedule of warrants activity	Schedule of warrants activity Weighted Average Aggregate Total Warrants Exercise Price Intrinsic Value Balance at December 31, 2022 139,555,757 $ 0.29 $ 150,667 Granted 7,242,428 0.29 Exercised (1,333,333 ) 0.29 Cancelled (3,545,000 ) — Balance at January 1, 2023 135,435,757 $ 0.29 $ 146,219 Granted — — Exercised — — Cancelled (10,140,000 ) — Balance at December 31, 2023 125,295,757 $ 0.30 $ 135,272
Schedule of warrants exercisable and outstanding	Schedule of warrants exercisable and outstanding Range of Weighted Average Weighted Average Aggregate Number Outstanding Remaining Exercise Prices Contractual Life (Years) Exercise Price Intrinsic Value $ 0.01 0.50 125,295,757 2.65 $ 0.30 $135,272 $ 0.51 1.00 125,295,757 — — — 125,295,757 $135,272

ORGANIZATION, NATURE OF BUSIN_2

ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 56,300,000	$ 54,000,000
Working capital deficiency	7,600,000	7,000,000
Cash used in operating activities	1,100,000	2,800,000
Cash	$ 55,248	$ 30,340

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Finished goods
Work in process
Raw materials and supplies
Total inventory

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	Dec. 31, 2023
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Machinery [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years
Warrants term
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total fixed assets	$ 931,438	$ 931,438
Accumulated depreciation	(529,167)	(401,201)
Total fixed assets, net	402,271	530,237
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Total fixed assets	203,193	203,193
Machinery [Member]
Property, Plant and Equipment [Line Items]
Total fixed assets	$ 728,245	$ 728,245

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Accrued payroll and taxes	$ 202,187	$ 22,847
Accrued interest	998,826	340,521
Other accrued expenses	64,096	775,502
Total accrued expenses	$ 1,265,109	$ 1,138,870

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Accrued legal fees		$ 165,000
Total accrued legal liability		$ 165,000

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 5) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	134,789,603	148,003,598
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	1,477,778	1,477,778
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	125,295,757	139,555,757
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	8,016,068	8,016,068

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 6)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Expected price volatility, minimum	162.12%	144.79%
Expected price volatility, maximum	167.20%	148.70%
Risk-free interest rate, minimum	0.78%	0.78%
Risk-free interest rate, maximum	1.26%	1.26%
Expected life in years	5 years	5 years
Dividend yield

SUMMARY OF SIGNIFICANT ACCOU_11

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 7) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Net operating loss carryforwards	$ 2,169	$ 7,587
Accruals and allowances	1,265	454
ROU liability amortization		359
Stock-based compensation		1,344
Total deferred tax assets	3,434	9,744
Valuation allowance	(3,434)	(9,744)
Total deferred tax assets net of valuation allowance
Deferred tax liabilities:
ROU asset amortization		(333)
Depreciation	(127)	(101)
Total deferred tax liabilities	(127)	(434)
Valuation allowance	127	434
Total deferred tax liabilities net of valuation allowance
Net deferred tax assets

SUMMARY OF SIGNIFICANT ACCOU_12

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash insured amount	$ 250,000
Amount of inventory reserve	0	$ 0
Depreciation expense	127,967	100,670
Impairment of assets		2,599,585
Share based compensation	20,000	1,783,284
Prepaid expense and other assets	0	0
Equity based compensation expense	0	509,013
Valuation allowance	3,400,000	9,700,000
Operating loss carryforwards	56,200,000	$ 54,000,000
Increase in valuation allowance	5,500,000
Federal net operating losses	28,400,000
Federal net operating losses expired amount if not utilized	27,200,000
Uncertain income tax positions	$ 0
Warrant [Member]
Common stock options	0	11,303,030
Options Held [Member]
Common stock options	0	0
Common Stock [Member]
Stock issued for cash	2,000,000	8,316,652

OPERATING LEASE (Details Narrat

OPERATING LEASE (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 25, 2019	Dec. 31, 2023	Dec. 31, 2022	Jan. 18, 2019
Operating Lease
Base rent obligation	$ 33,825
Present value of lease payments				$ 1,405,804
Lease term			5 years 1 month 24 days
Weighted average discount rate			15%
Operating lease rent expense		$ 0	$ 424,593

NOTES PAYABLE _ CONVERTIBLE (De

NOTES PAYABLE – CONVERTIBLE (Details Narrative) - USD ($)		12 Months Ended
	Aug. 03, 2020	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Feb. 16, 2021	Feb. 12, 2021	Jul. 08, 2020
Short-Term Debt [Line Items]
Note payable - convertible		$ 0	$ 0
Par value of share		$ 0.001	$ 0.001
Principal amount						$ 1,610,005	$ 191,965
Accrued interest			$ 159,630	$ 63,310			$ 15,729
Interest expense		$ 5,625	122
Accrued interest		0	0
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Interest expense		$ 0	$ 10
Unsecured Convertible Promissory Note With Accredited Investor [Member]
Short-Term Debt [Line Items]
Amount of debt conversion	$ 10,000
Interest rate	18%
Debt instrument interest rate	18%
Debt maturity	Feb. 03, 2021
Par value of share	$ 0.001
Proceeds from convertible debt	$ 500,000
Conversion price	$ 0.01
Principal amount					$ 10,000
Accrued interest					$ 1,007

NOTES PAYABLE _ CONVERTIBLE __2

NOTES PAYABLE – CONVERTIBLE – RELATED PARTY (Details Narrative) - USD ($)					1 Months Ended	12 Months Ended
	Sep. 15, 2022	May 12, 2021	Feb. 12, 2021	Aug. 03, 2020	Feb. 16, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jul. 08, 2020	Dec. 31, 2018
Short-Term Debt [Line Items]
Notes payable - convertible - related party						$ 2,144,357	$ 2,144,357
Interest rate										4%
Par value of share						$ 0.001	$ 0.001
Accrued interest							$ 159,630	$ 63,310	$ 15,729
Face Amount			$ 1,610,005						$ 191,965
Repayments of Convertible Debt
Gain on extinguishment of debt
Accrued liabilities						1,207,545	438,870
Interest expense						5,625	122
Convertible Note Payable [Member]
Short-Term Debt [Line Items]
Accrued interest						554,595	107,218
Interest expense						$ 0	$ 107,218
Secured Convertibl Ppromissory Note [Member]
Short-Term Debt [Line Items]
Face Amount	$ 2,144,357
Interest rate during period	20%
Amended principal	$ 1,689,746
Accrued liabilities	$ 454,612
Unsecured Convertible Promissory Note With Michael V Barbera [Member]
Short-Term Debt [Line Items]
Proceeds from convertible debt				$ 25,000
Interest rate				18%
Amount of debt conversion				$ 500,000	$ 25,000
Conversion price				$ 0.01
Accrued interest					$ 2,518
Website Development [Member]
Short-Term Debt [Line Items]
Amount of debt conversion				$ 1,000,000
Website Development [Member] | Louis Demaio As Trustee [Member]
Short-Term Debt [Line Items]
Face Amount				$ 750,000
Number Outstanding
Short-Term Debt [Line Items]
Interest rate		20%	20%
Face Amount		$ 1,689,746
Debt Instrument, Term			3 months
Repayments of Convertible Debt		1,610,005	$ 1,000,000
Accrued interest paid		$ 79,742	$ 110,005
Issued to the noteholders		7,500,000	15,000,000
Warrants term		5 years	5 years
Gain on extinguishment of debt			$ 3,686,123
Exercise price		$ 0.35
Gain on extinguishment of debt		$ 1,874,705

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)				1 Months Ended	12 Months Ended
	Apr. 09, 2021	Apr. 02, 2021	Jul. 08, 2020	Apr. 16, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 12, 2023	Nov. 02, 2023	Sep. 11, 2023	Jun. 25, 2023	Jun. 05, 2023	May 12, 2023	Apr. 28, 2023	Apr. 12, 2023	Mar. 24, 2023	Mar. 03, 2023	Feb. 24, 2023	Feb. 14, 2023	Sep. 22, 2022	Sep. 09, 2022	Aug. 31, 2022	Aug. 29, 2022	Aug. 22, 2022	Dec. 31, 2021	Feb. 25, 2021	Feb. 12, 2021	Dec. 31, 2018
Debt Instrument [Line Items]
Other notes payable					$ 270,000	$ 605,000
Interest rate																											4%
Notes Payable																											$ 260,425
Debt principal amount			$ 191,965																							$ 1,610,005
Accrued interest			$ 15,729			159,630																		$ 63,310
Notes payable					270,000	304,243
Interest expense					5,625	122
Promissory Note Agreement 1 [Member]
Debt Instrument [Line Items]
Interest rate																									1%
Debt principal amount																									$ 165,747
Notes payable						0																		165,747
Promissory Note [Member]
Debt Instrument [Line Items]
Interest rate	18%	18%		18%			20%	20%	20%	20%	20%	20%	20%	20%	20%	20%	20%	20%	18%	10%	10%	10%	10%
Debt principal amount	$ 50,000	$ 200,000		$ 25,000			$ 75,000	$ 100,000	$ 150,000	$ 200,000	$ 100,000	$ 100,000	$ 100,000	$ 150,000	$ 15,000	$ 15,000	$ 50,000	$ 10,000	$ 42,500	$ 60,000	$ 37,000	$ 25,000	$ 20,000
Common stock warrants issued	500,000	2,000,000		250,000
Warrants exercise price		$ 0.20		$ 0.25
Warrant expire term		5 years		5 years
Debt instrument, term	5 years
Promissory Note 1 [Member]
Debt Instrument [Line Items]
Interest rate				18%					20%										18%	10%	10%	10%	10%
Debt principal amount				$ 20,000					$ 50,000										$ 42,500	$ 10,000	$ 13,000	$ 10,000	$ 5,000
Common stock warrants issued				200,000
Warrants exercise price				$ 0.25
Debt instrument, term				5 years
Promissory Note 2 [Member]
Debt Instrument [Line Items]
Interest rate				18%																10%
Debt principal amount				$ 300,000																$ 10,000
Accrued interest					5,199
Conversion of shares				6,000,000
Common stock warrants issued				3,000,000
Warrants exercise price				$ 0.25
Debt instrument, term				5 years
Loss on extinguishment					$ 1,487,386
Unsecured Debt [Member]
Debt Instrument [Line Items]
Stock issued for cash			150,000
Amount of debt forgiven			$ 57,694
Conversion of shares			1,136,364
Warrant expire term			five
Exercise price			$ 0.396
Financing Arrangements [Member]
Debt Instrument [Line Items]
Notes payable						$ 5,200																		$ 6,015

NOTES PAYABLE _ RELATED PARTY (

NOTES PAYABLE – RELATED PARTY (Details Narrative) - USD ($)																			1 Months Ended	12 Months Ended
	Dec. 12, 2023	Nov. 02, 2023	Sep. 11, 2023	Jun. 25, 2023	Jun. 05, 2023	May 12, 2023	Apr. 28, 2023	Apr. 12, 2023	Mar. 03, 2023	Feb. 24, 2023	Feb. 14, 2023	Sep. 22, 2022	Sep. 09, 2022	Aug. 31, 2022	Aug. 29, 2022	Aug. 22, 2022	Apr. 02, 2022	Apr. 02, 2021	Mar. 24, 2023	Dec. 31, 2023	Dec. 31, 2022	Apr. 16, 2021	Apr. 09, 2021	Feb. 12, 2021	Jul. 08, 2020	Apr. 13, 2020	Jan. 16, 2020	Dec. 31, 2018
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Notes payable - related party																				$ 1,750,000	$ 605,000
Principal amount																								$ 1,610,005	$ 191,965
Interest rate																												4%
Interest expense																				566,429	121,932
Accrued interest																				$ 287,725	$ 121,932
Promissory Note [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Principal amount	$ 75,000	$ 100,000	$ 150,000	$ 200,000	$ 100,000	$ 100,000	$ 100,000	$ 150,000	$ 15,000	$ 50,000	$ 10,000	$ 42,500	$ 60,000	$ 37,000	$ 25,000	$ 20,000		$ 200,000	$ 15,000			$ 25,000	$ 50,000
Interest rate	20%	20%	20%	20%	20%	20%	20%	20%	20%	20%	20%	18%	10%	10%	10%	10%		18%	20%			18%	18%
Maturity date	Dec. 11, 2024	Nov. 01, 2024	Sep. 10, 2024	Jul. 24, 2024	Jun. 04, 2024	May 11, 2024	Apr. 27, 2024	Apr. 11, 2024	Mar. 02, 2024	Feb. 23, 2024	Feb. 13, 2024	Sep. 22, 2024	Aug. 16, 2024	Aug. 31, 2024	Aug. 29, 2024	Aug. 22, 2024			Mar. 23, 2024
Promissory Note 1 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Principal amount			$ 50,000									$ 42,500	$ 10,000	$ 13,000	$ 10,000	$ 5,000						$ 20,000
Interest rate			20%									18%	10%	10%	10%	10%						18%
Maturity date			Sep. 10, 2024									Sep. 22, 2024	Sep. 09, 2024	Aug. 31, 2024	Aug. 29, 2024	Aug. 22, 2024
Promissory Note 2 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Principal amount													$ 10,000									$ 300,000
Interest rate													10%									18%
Maturity date													Sep. 09, 2024
Promissory Note 3 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Principal amount													$ 15,000
Interest rate													10%
Maturity date													Sep. 09, 2024
Promissory Note 4 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Principal amount													$ 15,000
Interest rate													10%
Maturity date													Sep. 09, 2024
Michael V Barbera [Member] | Promissory Note [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Principal amount																		$ 150,000									$ 50,000
Interest rate																		18%								12%	10%
Maturity date																	Apr. 01, 2024	Oct. 02, 2022
Issuance of shares																		1,500,000
Paul Sallarulo [Member] | Promissory Note [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Principal amount																		$ 150,000
Interest rate																		18%
Maturity date																	Apr. 01, 2024	Oct. 02, 2022
Issuance of shares																		1,500,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		12 Months Ended
	Jul. 09, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 10, 2021
Product Liability Contingency [Line Items]
Options to purchase restricted common shares				40,000,000
Rebar [Member]
Product Liability Contingency [Line Items]
Revenue		$ 0	$ 37,116
Basanite [Member]
Product Liability Contingency [Line Items]
Number of shares issued	500,000
Number of value issued	$ 165,000

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Aug. 17, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, price per share			$ 0.275
Stock issued during period, value	$ 1,300,000	$ 649,591
Stock-based compensation	164,266	509,013
Subscription liability	$ 0	$ 1,300,000
Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of stock issued	2,000,000
Stock issued during period, value	$ 100,000
Restricted Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of stock issued	0	2,121,212
Stock issued during period, value	$ 0	$ 649,591
Warrant B [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrant or right, exercise price of warrants or rights			0.33
Warrant A [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrant or right, exercise price of warrants or rights			$ 0.33

OPTIONS AND WARRANTS (Details)

OPTIONS AND WARRANTS (Details) - Equity Option [Member] - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Offsetting Assets [Line Items]
Options Outstanding, beginning	1,477,778	1,477,778
Weighted Average Exercise Price, beginning	$ 0.27	$ 0.27
Aggregate Intrinsic Value, beginning	$ 798
Cancelled
Weighted Average Exercise Price, Cancelled
Issued
Weighted Average Exercise Price, issued
Exercised
Weighted Average Exercise Price, Exercised
Options Outstanding, ending	1,477,778	1,477,778
Weighted Average Exercise Price, ending	$ 0.27	$ 0.27
Aggregate Intrinsic Value,ending	$ 798	$ 798

OPTIONS AND WARRANTS (Details 1

OPTIONS AND WARRANTS (Details 1) - Equity Option [Member] - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Offsetting Assets [Line Items]
Number Outstanding	1,477,778	1,477,778	1,477,778
Average Intrinsic Value	$ 6,798
Price Range One [Member]
Offsetting Assets [Line Items]
Range of Exercise Prices, Lower	$ 0.01
Range of Exercise Prices, Upper	$ 0.50
Exercise Price Range One [Member]
Offsetting Assets [Line Items]
Number Outstanding	1,477,778
Weighted Average Remaining Contractual Life (Years)	2 years 4 months 20 days
Weighted Average Exercise Price	$ 0.27
Average Intrinsic Value	$ 6,798
Price Ranges Two [Member]
Offsetting Assets [Line Items]
Range of Exercise Prices, Lower	$ 0.51
Range of Exercise Prices, Upper	$ 1
Exercise Price Range Two [Member]
Offsetting Assets [Line Items]
Number Outstanding
Weighted Average Remaining Contractual Life (Years)	3 months 7 days
Weighted Average Exercise Price
Average Intrinsic Value

OPTIONS AND WARRANTS (Details 2

OPTIONS AND WARRANTS (Details 2) - Warrant [Member] - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options Outstanding, beginning	135,435,757	139,555,757
Weighted Average Exercise Price, beginning	$ 0.29	$ 0.29
Aggregate Intrinsic Value, beginning	$ 146,219	$ 150,667
Granted		7,242,428
Weighted Average Exercise Price, Granted		$ 0.29
Exercised		(1,333,333)
Weighted Average Exercise Price, Exercised		$ 0.29
Cancelled	(10,140,000)	(3,545,000)
Weighted Average Exercise Price, Cancelled
Exercised		1,333,333
Options Outstanding, ending	125,295,757	135,435,757
Weighted Average Exercise Price, ending	$ 0.30	$ 0.29
Aggregate Intrinsic Value,ending	$ 135,272	$ 146,219

OPTIONS AND WARRANTS (Details 3

OPTIONS AND WARRANTS (Details 3) - Warrant [Member]	12 Months Ended
	Dec. 31, 2023 USD ($) $ / shares shares
Number Outstanding | shares	125,295,757
Average Intrinsic Value | $	$ 135,272
Exercise Price Range One [Member]
Range of Exercise Prices, Lower	$ 0.01
Range of Exercise Prices, Upper	$ 0.50
Number Outstanding | shares	125,295,757
Weighted Average Remaining Contractual Life (Years)	2 years 7 months 24 days
Weighted Average Exercise Price	$ 0.30
Average Intrinsic Value | $	$ 135,272
Exercise Price Range Two [Member]
Range of Exercise Prices, Lower	$ 0.51
Range of Exercise Prices, Upper	$ 1
Number Outstanding | shares	125,295,757
Weighted Average Exercise Price
Average Intrinsic Value | $